PURPOSE OF REVIEW: Transurethral resection of bladder cancer (TURBT) is in its standard form an inherently imperfect technique. Fluorescence-guided photodynamic diagnosis (PDD) represents one way to improve the outcome by enhancing tumour detection. Fluorescence has been used in connection with bladder cancer since the 1970s, with a number of studies being published since then. However, the method is still not recommended as a standard part of TURBT mainly because of the limited level of evidence of concerned studies, questionable cost-effectiveness and even contradictory results. The review lists the latest articles covering this topic. RECENT FINDINGS: Several recently published meta-analyses reviewed a series of randomized controlled trials (RCTs) concerning PDD assisted TURBT. Results were generally supporting the positive effect on reduction of recurrence rate. However, the mentioned meta-analyses are overlapping in terms of reviewed RCT that provide only a low level of evidence according to a recent Cochrane review. Supposed limitations of PDD (timing of the procedure, low specificity) and possible solutions are also covered. SUMMARY: Most of the published data confirmed reduced early recurrence rate after PDD assisted TURBT comparing to standard TURBT. Its impact on late recurrence rate, progression rate or cost-effectiveness has not been sufficiently demonstrated.

Department of Urology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

See more in PubMed

Brausi M. La Resezione Trans-Uretrale dei tumori della vescica: una tecnica semplice e molta praticata ma con risultati controversi [Transurethral resection of bladder cancer: a simple and diffusely-performed technique but with controversial outcomes]. Urologia 2013; 80:127–129. [in Italian].

Buaban K, Attawettayanon W, Sirisreetreerux P, et al. Comparison of 3-month recurrence rates after white-light versus narrow-band imaging transurethral resection for nonmuscle invasive bladder cancer: a prospective, randomized control trial. J Med Assoc Thai 2018; 101:463–469.

Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49:466–475. discussion 475–7.

Nonaka K, Nishimura M, Kita H. Role of narrow band imaging in endoscopic submucosal dissection. World J Gastrointest Endosc 2012; 4:387–397.

Bryan RT, Billingham LJ, Wallace DM. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 2008; 101:702–705. discussion 705–6.

Bus MT, de Bruin DM, Faber DJ, et al. Optical diagnostics for upper urinary tract urothelial cancer: technology, thresholds, and clinical applications. J Endourol 2015; 29:113–123.

Freund JE, Buijs M, Savci-Heijink CD, et al. Optical coherence tomography in urologic oncology: a comprehensive review. SN Compr Clin Med 2019; 1:67–84.

Chen SP, Liao JC. Confocal laser endomicroscopy of bladder and upper tract urothelial carcinoma: a new era of optical diagnosis? Curr Urol Rep 2014; 15:437.

Teoh JY, Kamat AM, Black PC, et al. Recurrence mechanisms of nonmuscle-invasive bladder cancer – a clinical perspective. Nat Rev Urol 2022; 19:280–294.

Fukuhara H, Yamamoto S, Karashima T, Inoue K. Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy. Int J Clin Oncol 2021; 26:18–25.

Sari Motlagh R, Mori K, Laukhtina E, et al. Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of nonmuscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized trials. BJU Int 2021; 128:280–289.

Veeratterapillay R, Gravestock P, Nambiar A, et al. Time to turn on the blue lights: a systematic review and meta-analysis of photodynamic diagnosis for bladder cancer. Eur Urol Open Sci 2021; 31:17–27.

Maisch P, Koziarz A, Vajgrt J, et al. Blue versus white light for transurethral resection of nonmuscle invasive bladder cancer. Cochrane Database Syst Rev 2021; 12:CD013776.

Andersson M, Berger M, Zieger K, et al. The diagnostic challenge of suspicious or positive malignant urine cytology findings when cystoscopy findings are normal: an outpatient blue-light flexible cystoscopy may solve the problem. Scand J Urol 2021; 55:263–267.

Miyake M, Nishimura N, Nakai Y, et al. Photodynamic diagnosis-assisted transurethral resection using oral 5-aminolevulinic acid decreases the risk of repeated recurrence in non-muscle-invasive bladder cancer: a cumulative incidence analysis by the person-time method. Diagnostics (Basel) 2021; 11:185.

Heer R, Lewis R, Vadiveloo T, et al. A randomized trial of PHOTOdynamic surgery in non–muscle-invasive bladder cancer. NEJM Evid. 2022;1. Doi:10.1056/EVIDoa2200092.

Owari T, Iwamoto T, Anai S, et al. The sustaining of fluorescence in photodynamic diagnosis after the administration of 5-aminolevulinic acid in carcinogen-induced bladder cancer orthotopic rat model and urothelial cancer cell lines. Photodiagn Photodyn Ther 2021; 34:102309.

Yamamoto S, Fukuhara H, Karashima T, Inoue K. Real-world experience with 5-aminolevulinic acid for the photodynamic diagnosis of bladder cancer: Diagnostic accuracy and safety. Photodiagn Photodyn Ther 2020; 32:101999.

Babjuk M, et al. Guidelines on nonmuscle-invasive bladder cancer (Ta, T1 and CIS). EAU Guidelines Office, 2022. The Netherlands: European Association of Urology Guidelines Office Arnhem.

Hagimoto H, Makita N, Mine Y, et al. Comparison between 5-aminolevulinic acid photodynamic diagnosis and narrow-band imaging for bladder cancer detection. BMC Urol 2021; 21:180.

Polikarpov DM, Campbell DH, Zaslavsky AB, et al. Glypican-1 as a target for fluorescence molecular imaging of bladder cancer. Int J Urol 2021; 28:1290–1297.

Kalyagina N, Loshchenov M, Amouroux M, et al. Two diagnostic criteria of optical spectroscopy for bladder tumor detection: clinical study using 5-ALA induced fluorescence and mathematical modeling. Photodiagn Photodyn Ther 2020; 31:101829.

Miyake M, Nishimura N, Inoue T, et al. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with nonmuscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study). Trials 2021; 22:136.